A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
Interferon Beta 1b has been studied across 18 research domains including 🛡️ Immunity, 😴 Sleep, ⏳ Longevity & Aging, 🔬 Inflammation, ✨ Skin & Hair. The primary research focus is 🛡️ Immunity with 99% of studies addressing this area.
This evidence profile for Interferon Beta 1b is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.